RMD ResMed Inc.
USHealthcareAs of 2026-07-10 16:00
Why RMD matters now
ResMed Inc. (RMD) is a US stock in Healthcare. The latest InvestLog snapshot shows $203.87 with -2.20% on the session and $29.57B in market capitalization; recent performance reads 1-month -9.22% and YTD -21.69%.
The latest financial table shown here is Q3 2026, with revenue of $1.43B, net income of $398.7M, and EPS of $2.71. Investors can compare that operating picture with valuation signals such as P/E 22.21 and FCF yield 6.4%.
The latest indexable market news headline is "Resmed Divests MatrixCare Business to Sharpen Focus on Connected Care" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Hold with a median target of $265.00; recent insider activity includes Farrell Michael J. filing M-Exempt; recent congressional disclosure data includes Ro Khanna Purchase. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
22.21
PEG
1.17
P/B
4.26
P/S
4.94
EV/EBITDA
12.14
DCF Value
$309.17
FCF Yield
6.4%
Div Yield
1.3%
Margins & Returns
Gross Margin
61.7%
Operating Margin
34.3%
Net Margin
27.4%
ROE
24.4%
ROA
17.3%
ROIC
19.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $1.43B | $398.7M | $2.71 |
| Q2 2026 | $1.42B | $392.6M | $2.68 |
| Q1 2026 | $1.34B | $348.5M | $2.37 |
| Q4 2025 | $1.35B | $379.7M | $2.58 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$264.86
Target (Median)
$265.00
Target Range
$225.00 - $314.00
Trading Activity
Insider Trades
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.78
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.